How DNA Testing Will Accelerate Precision Medicine, Preventive Care

In May 2018, Geisinger Health System announced that it would soon include genomic sequencing in routine clinical care to advance precision medicine and improve patient outcomes.

The goal of the project, Geisinger stated at the time, was to go beyond standard methods of care like cholesterol checks, mammographies, and colonoscopies to identify patients at high risk of certain conditions. 

“Originally, we offered genomic sequencing only to certain patient groups, so that we could test people’s perceptions of the test and to make sure everything was running smoothly from an operational standpoint. We picked two of our larger clinics at Geisinger and did a slow launch,” said Christa Martin, PhD, FACMG, director of the Autism & Developmental Medicine Institute at Geisinger.

“Since we launched the project, we’ve tested over 800 patients. We're getting ready to launch DNA screening in three additional clinics within the next few months, and we'll be offering it to all patients.”

The full Health IT Analytics article can be viewed at this link.